Similar Search Results

Perspectives on Firm Decision Making During Risky Technology Acquisitions

Powell, Adam C. - 2011

A novel survey dataset on computed tomography (CT) machine acquisition is used to explore which theories best answer two questions from the decision making literature. First, what determines how much uncertainty a firm has when investing in updated technology? Second, what determines the value...

Persistent link: https://www.econbiz.de/10009438770

Does the Profit Motive Make Jack Nimble? Ownership Form and the Evolution of the U.S. Hospital Industry

Chakravarty, Sujoy; Gaynor, Martin; Klepper, Stephen; … - 2005

We examine the evolving structure of the U.S. hospital industry since 1970, focusing on how ownership form influences … hospital chain significantly decreases the probability of exit for for-profits, but not not-for-profits. …

Persistent link: https://www.econbiz.de/10009441040

Does the Profit Motive Make Jack Nimble? Ownership Form and the Evolution of the U.S. Hospital Industry

Chakravarty, Sujoy; Gaynor, Martin; Klepper, Steven; … - 2005

Persistent link: https://www.econbiz.de/10009441241

Analysis of corporate acquisitions by medical device manufacturers

DeGraaff, Robert A - 2006

This doctoral thesis draws on the financial economics, strategic management, product innovation, and health technology literatures to investigate and explain conditions under which corporate acquisitions in the medical device industry have enhanced or eroded shareholder wealth and financial...

Persistent link: https://www.econbiz.de/10009438806

Price regulation, capital market imperfections, and strategic R&D investment behavior in the pharmaceutical industry: Consequences for innovation

Vernon, John Andrew - 2003

The research in this thesis focuses on the pharmaceutical R&D investment decision. The two primary hypotheses I test are that: (1) capital market imperfections in the market for pharmaceutical R&D finance impart a lower cost of capital to internal funds relative to external debt and equity, and...

Persistent link: https://www.econbiz.de/10009439232

Cross-country generalizability of quality-of-lifescores in atopic dermatitis

Rencz, Fanni - 2019

Persistent link: https://www.econbiz.de/10012582931

Hippocratic PostgreSQL

Padma, J; Silva, Yasin; Arshad, Mohamed; Aref, Walid - 2009

Privacy preservation has become an important requirement in information systems that deal with personal data. In many cases this requirement is imposed by laws that recognize the right of data owners to control whom their information is shared with and the purposes for which it can be shared....

Persistent link: https://www.econbiz.de/10009430509

Lean indicators in hospital/healthcare settings and the role of leadership in the diffusion of performance improvement strategies

Ezzeddine, Ahmad M - 2006

This study examines the process improvement initiatives undertaken at a community-based hospital to improve patient … satisfaction and the financial and competitive position of the hospital through the implementation and marketing of the 29 Minute … is believed that the adoption of the 29 minute strategy, which was initiated by a change in the hospital's main front …

Persistent link: https://www.econbiz.de/10009431730

A new look at hospital cost function estimation

Velagapudi, Kalyani R Mandadi - 1995

The production of hospital care can be viewed as a two-tiered production process. At the first tier, intermediate … estimating a hospital cost function and when evaluating the performance of the hospitals. This dissertation uses 1990 hospital … of hospital efficiencies. While T.T suggests mild economies of scale, Q.T indicates the presence of significant economies …

Persistent link: https://www.econbiz.de/10009431756

Did Michigan's policies reduce the daily cost of drug therapy for its dual eligible beneficiaries?

Kibicho, Jennifer Waruguru - 2007

Background . Michigan Medicaid outpatient prescription drug program implemented the following four policies to address rising expenditures considered "out of control": (1) February 2002: Preferred Drug List (PDL); (2) February 2003: Joint Purchasing Arrangement (JPA); (3) November 2003: Maximum...

Persistent link: https://www.econbiz.de/10009431783